March 15, 2019
American Health Line rounds up the latest health care news in the states.
March 14, 2019
FDA on Wednesday unveiled highly anticipated draft guidance intended to restrict where and how flavored e-cigarettes are sold in the United States.
Former Rep. Beto O'Rourke (D-Texas) on Thursday announced that he is seeking the 2020 Democratic nomination for president, and indicted health care will be a priority in his campaign.
FDA on Tuesday announced it has approved a new generic blood pressure and heart failure medication to help address a shortage that resulted from multiple drug recalls.
The Department of Defense on Tuesday approved a new policy that will bar many transgender individuals from serving in the U.S. military.
March 13, 2019
HHS Secretary Alex Azar on Tuesday announced that Ned Sharpless, director of the National Cancer Institute, will become the acting commissioner of FDA when FDA Commissioner Scott Gottlieb departs.
Two large operators of Blue Cross and Blue Shield health plans on Monday announced that they plan to merge their administrative, management, and other functions to create one combined structure.
FDA on Friday approved Roche's Tecentriq to treat patients with locally advanced or metastatic triple-negative breast cancer who have the PD-L1 molecule that can block T cells from attacking a tumor.
In the first case of its kind in more than 30 years, a six-year-old boy from Oregon who had never been vaccinated entered an eight-week long fight for his life after falling ill with tetanus in 2017, according to a CDC report published last week.
Sen. Bernie Sanders (I-Vt.) in the coming weeks plans to introduce a new version of his so-called "Medicare-for-All" legislation that would expand benefits under the bill to include long-term care coverage.
Advisory Board. All rights reserved.